ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a multicenter, randomized, double-blinded, placebo-controlled clinical study of ORKA-002 in adult participants with moderate-to-severe HS.
Epistemonikos ID: e5fc747b56f12daa6fc6203d660d236c10c0def7
First added on: Aug 26, 2026